Evidence map›Paper›PMID 40842012›Full record

ArticleJournal of translational medicine2025

OncoMet: a deep learning framework for the prediction of oncogenic signaling pathways and metastasis in esophageal cancer patients using histopathology images from primary tumors.

Syed Wajid Aalam, Abdul Basit Ahanger, Tabasum Majeed, Ab Naffi Ahanger, Tariq Masoodi, Ajaz A Bhat, Assif Assad, Muzafar Ahmad Macha, Muzafar Rasool Bhat

Abstract read
In one paragraph

Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Syed Wajid AalamDepartment of Computer Science, Islamic University of Science and Technology (IUST), Awantipora, Kashmir, India.
Abdul Basit AhangerDepartment of Computer Science, Islamic University of Science and Technology (IUST), Awantipora, Kashmir, India.
Tabasum MajeedDepartment of Computer Science and Engineering, Islamic University of Science and Technology (IUST), Awantipora, Kashmir, India.
Ab Naffi AhangerDepartment of Computer Science, Islamic University of Science and Technology (IUST), Awantipora, Kashmir, India.
Tariq MasoodiCanary Oncoceutics Inc, 20E Thomas Road, Suite 2203, Phoenix, AZ, USA.
Ajaz A BhatMetabolic and Mendelian Disorders Clinical Research Program, Precision OMICs Research and Translational Science, Sidra Medicine, Doha, Qatar.
Assif AssadCentre for Artificial Intelligence, Islamic University of Science and Technology, Awantipora, Kashmir, India.
Muzafar Ahmad MachaWatson-Crick Centre for Molecular Medicine, Islamic University of Science and Technology (IUST), Awantipora, Kashmir, India. muzafar.macha@iust.ac.in.
Muzafar Rasool BhatDepartment of Computer Science, Islamic University of Science and Technology (IUST), Awantipora, Kashmir, India. muzafarrasool@gmail.com.

Funding

Department of Science and Technology, Govt. of India SR/PURSE/2022/121Indian Council of Medical Research ID No. 2022-16465
6 · The paper itself

Abstract

backgroundDespite recent advancements in the diagnosis and prognosis of Esophageal cancer (EC), it remains among the leading causes of cancer-related mortality. Timely and cost-effective diagnosis, particularly in predicting the risk of metastasis and identifying the deregulation of oncogenic signaling pathways, could open new frontiers towards precision medicine and targeted therapy of EC. However, current diagnostic practices in identifying metastasis and deregulated oncogenic pathways involve molecular testing, which is time-consuming and costly. Advances in deep learning analysis of digital pathological imagery data offer promising avenues for automating and enhancing cancer diagnosis and risk stratification.

methodsHigh-resolution H&E-stained diagnostic whole slide images were obtained from the open repository of The Cancer Genome Atlas (TCGA). The WSIs underwent several pre-processing steps, including patching, color normalization and augmentation. A deep learning model was designed and trained on WSI data and tissue-level labels to generate image feature representations for predicting metastatic potential and identifying the deregulation of four major oncogenic signaling pathways, viz. mTOR, PTEN, p53, and PI3K/AKT.

resultsThe proposed model achieved an AUC of 0.92 for predicting metastatic risk and AUCs ranging from 0.64 to 0.92 for the identification of deregulated oncogenic pathways. In a first, we were able to operate the model without the need for exhaustive patch-level annotations, relying instead on slide-level annotations only.

conclusionIn this work, we highlighted the transformative potential of deep learning in accurately detecting metastasis and identifying deregulated oncogenic pathways from H&E slides using slide-level annotation, thus opening new doors in precision medicine and targeted therapy.

Indexed as

CarcinogenesisDeep LearningEsophageal NeoplasmsSignal TransductionHumansImage Processing, Computer-AssistedNeoplasm MetastasisROC CurveColor normalizationDeep learningEsophageal cancerHistopathologyMachine learningMetastasisPatchingSignaling pathwaysWhole slide images

Identifiers

PMID40842012
PMCPMC12372372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.